Exhibit 99.1

		news
		FOR IMMEDIATE RELEASE
INVESTOR CONTACT:		MEDIA CONTACT:
Mark Kimbrough		Ed Fishbough
615-344-2688		615-344-2810

HCA Reports First Quarter 2015 Results

Board Authorizes Additional $1 Billion Share Repurchase

Plans to Increase 3-Year Capital Plan by $500 Million

Nashville, Tenn., May 5, 2015 – HCA Holdings, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2015.

Key first quarter metrics (all percentage changes compare 1Q 2015 to 1Q 2014 unless noted):

On May 4, 2015, HCA’s Board of Directors authorized an additional share repurchase program for up to $1 billion of the Company’s outstanding common stock. Repurchases will be made in accordance with applicable securities laws from time to time in the open market, through privately negotiated transactions, or otherwise.

Today, the Company is also announcing a $500 million planned increase in its 3-year capital expenditures program to meet the growing capital investment opportunities in its existing markets. The updated capital investment program is expected to approximate $7.7 billion over the next three years, up from the previous plan of approximately $7.2 billion.

Revenues in the first quarter increased to $9.676 billion, compared to $8.832 billion in the first quarter of 2014. Net income attributable to HCA Holdings, Inc. totaled $591 million, or $1.36 per diluted share, compared to $347 million, or $0.76 per diluted share, in the first quarter of 2014. First quarter 2015 results include gains on sales of facilities of $9 million, or $0.01 per diluted share. Results for the first quarter of 2014 include gains on sales of facilities of $21 million, or $0.03 per diluted share, and also include legal claims costs of $78 million, or $0.11 per diluted share. Adjusted EBITDA totaled $1.961 billion compared to $1.644 billion in the first quarter of 2014. Adjusted EBITDA is a non-GAAP financial measure. A table reconciling net income attributable to HCA Holdings, Inc. to Adjusted EBITDA is included in this release.

1

Same facility equivalent admissions increased 6.8 percent in the first quarter of 2015 compared to the prior year period. Same facility admissions increased 5.1 percent compared to the prior year period. Same facility emergency room visits increased 11.5 percent in the first quarter of 2015, compared to the prior year period. Same facility inpatient surgeries increased 3.0 percent, while same facility outpatient surgeries increased 1.4 percent in the first quarter of 2015 compared to the same period of 2014. Same facility revenue per equivalent admission increased 1.6 percent in the first quarter of 2015 compared to the first quarter of 2014.

During the first quarter of 2015, salaries and benefits, supplies and other operating expenses totaled $7.753 billion, or 80.1 percent of revenues, compared to $7.227 billion, or 81.8 percent of revenues, in the first quarter of 2014.

Balance Sheet and Cash Flow

As of March 31, 2015, HCA Holdings, Inc.’s balance sheet reflected cash and cash equivalents of $586 million, total debt of $29.443 billion, and total assets of $31.288 billion. During the first quarter of 2015, capital expenditures totaled $446 million, excluding acquisitions. Cash flows provided by operating activities in the first quarter totaled $1.018 billion compared to $443 million in the prior year’s first quarter. As of March 31, 2015, HCA’s leverage ratio as measured by Total Debt/Adjusted EBITDA was 3.80x, compared to 3.96x as of December 31, 2014.

The Company repurchased approximately 5.2 million shares of its common stock during the first quarter of 2015. In addition, in April 2015, the Company repurchased approximately 3.8 million shares of its common stock beneficially owned by affiliates of Bain Capital Investors, LLC and certain charitable organizations that received shares of common stock previously held by the affiliates of Bain Capital Investors, LLC at a purchase price of $77.26 per share, the closing price of the Company’s common stock on the New York Stock Exchange on April 17, 2015, less a discount of 1 percent. The share repurchase was made pursuant to the Company’s existing $1.0 billion repurchase program adopted by the Company’s Board of Directors in February 2015. Through April 30, 2015, the Company has completed approximately $781 million of share repurchases under the program. The Company had approximately 419.179 million shares outstanding as of March 31, 2015.

As of March 31, 2015, HCA operated 168 hospitals and 113 freestanding surgery centers.

2015 Guidance

On April 15, 2015, the Company raised its previously issued financial guidance ranges for 2015.

2

The Company’s revised 2015 guidance contains a number of assumptions that remain unchanged from its February 2015 guidance, including:

Earnings Conference Call

HCA will host a conference call for investors at 10:00 a.m. Central Daylight Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The broadcast also will be available on a replay basis beginning this afternoon. The webcast can be accessed at: https://event.webcasts.com/starthere.jsp?ei=1060572 or through the Company’s Investor Relations web page, www.hcahealthcare.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include statements that do not relate solely to historical or current facts. Forward-looking statements can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, (2) the effects related to the implementation of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the “Health Reform Law”), possible delays in or complications related to implementation of the Health Reform Law, court challenges, the possible enactment of additional federal or state health care reforms and possible changes to the Health Reform Law and other federal, state or local laws or regulations affecting the health care industry, (3) the effects related to the continued implementation of the sequestration spending

3

reductions required under the Budget Control Act of 2011 (the “BCA”), and related legislation extending these reductions, and the potential for future deficit reduction legislation that may alter these spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (4) increases in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts, (5) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6) possible changes in Medicare, Medicaid and other state programs, including Medicaid upper payment limit programs or waiver programs, that may impact reimbursements to health care providers and insurers, (7) the highly competitive nature of the health care business, (8) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under managed care agreements, the ability to enter into and renew managed care provider agreements on acceptable terms and the impact of consumer driven health plans and physician utilization trends and practices, (9) the efforts of insurers, health care providers and others to contain health care costs, (10) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13) changes in accounting practices, (14) changes in general economic conditions nationally and regionally in our markets, (15) the emergence and effects related to infectious diseases, including Ebola; (16) future divestitures which may result in charges and possible impairments of long-lived assets, (17) changes in business strategy or development plans, (18) delays in receiving payments for services provided, (19) the outcome of pending and any future tax audits, disputes and litigation associated with our tax positions, (20) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (21) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments, and (22) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2014 and our other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

All references to “Company and “HCA” as used throughout this release refer to HCA Holdings, Inc. and its affiliates.

4

HCA Holdings, Inc.

Condensed Consolidated Comprehensive Income Statements

First Quarter

(Dollars in millions, except per share amounts)

5

HCA Holdings, Inc.

Supplemental Non-GAAP Disclosures

Operating Results Summary

(Dollars in millions, except per share amounts)

Management and investors review both the overall performance (including net income attributable to HCA Holdings, Inc., excluding gains on sales of facilities and legal claim costs, and GAAP net income attributable to HCA Holdings, Inc.) and operating performance (Adjusted EBITDA) of our health care facilities. Adjusted EBITDA and the Adjusted EBITDA margin (Adjusted EBITDA divided by revenues) are utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry. It is reasonable to expect that gains (losses) on sales of facilities and legal claim costs will occur in future periods, but the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our health care facilities and complicate period comparisons of our results of operations and operations comparisons with other health care companies.

Net income attributable to HCA Holdings, Inc., excluding gains on sales of facilities and legal claim costs, and Adjusted EBITDA are not measures of financial performance under GAAP, and should not be considered as alternatives to net income attributable to HCA Holdings, Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because net income attributable to HCA Holdings, Inc., excluding gains on sales of facilities and legal claim costs, and Adjusted EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, net income attributable to HCA Holdings, Inc., excluding gains on sales of facilities and legal claim costs, and Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies.

6

HCA Holdings, Inc.

Condensed Consolidated Balance Sheets

(Dollars in millions)

7

HCA Holdings, Inc.

Consolidated Statements of Cash Flows

First Quarter

(Dollars in millions)

8

HCA Holdings, Inc.

Operating Statistics

9